Product Details
Cefexiclav Powder for Oral Suspension 50 mg/31.25 mg/5 mL##
Cefixime; Clavulanic Acid (Clavulanate Potassium)50 mg/5 mL; 31.25 mg/5 mL
Suspension
ROA
Oral
Applicant Name
SJS Life Sciences Limited
NRN
B4-6583
Status
Active
Composition
Each 5 mL of reconstituted suspension contains: Cefixime BP (As Trihydrate) equivalent to Anhydrous Cefixime 50 mg, Clavulanate Potassium BP equivalent to Anhydrous Clavulanic Acid 31.25 mg Excipients q.s.
ATC Code
J01DD08
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 100 mL (in HDPE bottle)
Product Description
Powder for Oral Suspension 149 CMS-PP-233255 CEFEXICLAV POWDER FOR ORAL SUSPENSION 50MG/31.25MG/5ML CEFIXIME 50MG + CLAVULANIC ACID 31.25MG Cefixime Trihydrate Eq to Cefixime (A) 50mg, Diluted Potassium Clavulanate Eq. to Clavulanic Acid (A) 31.25mg, Sucrose (D)$ 937mg, Colloidal Anhydrous Silica 15mg, Carmellose Sodium (Sodium Carboxymethylcellulose) 25mg, Sodium Citrate 11.25mg, Sodium Benzoate 1.04mg, Essence Orange Powder (Firemenich) 13.10mg, Aspartame 6.360mg, Disodium Edetate 10mg B4-6583 Drugs Imported Products 1*100ML Prescription Only Medicine (POM) 10/5/2021 SJS LIFE SCIENCES LIMITED, 11, OLU AKERELE STREET, IKEJA, LAGOS 8114441430 sjslifesciencesltd@gmail.com GLOBELA LABORATORIES PRIVATE LIMITED, PLOT NO. 5536, ROAD NO. 55, G.I.D.C. ESTATE, SACHIN, SURAT – 394 230, INDIA, India
Manufacturer Name
Globela Pharma Pvt Ltd
Manufacturer Country
INDIA
Approval Date
2023-07-06
Expiry Date
2028-07-05